title: The single nucleotide polymorphism CRTh2 rs533116 is associated with allergic asthma and increased expression of CRTh2.
abstract: BACKGROUND
  CRTh2 (chemoattractant-receptor homologous molecule expressed on Th2 cells) is expressed by Th2 cells and other cells involved in allergic inflammation. Single nucleotide polymorphisms (SNPs) in CRTh2 (rs11571288, rs545659, rs634681) have been associated with various phenotypes of allergy in ethnically distinct populations. Here, we assessed the association between CRTh2 rs533116 and allergic asthma, expression of CRTh2 and Th2 cytokine production.
  
  
  METHODS
  CRTh2 rs533116 was genotyped in an ethnically diverse population (n = 1282). The proportion of cells expressing CRTh2 was determined in peripheral blood from subjects with allergic airways disease and controls as well as with in vitro differentiated Th2 cells. Receptor function was assessed by stimulating Th2 cells with the CRTh2-specific agonist 13,14-dihydro-15-keto-PGD(2)  (DK-PGD(2) ) and measuring IL-4 and IL-13 by intracellular staining and ELISA.
  
  
  RESULTS
  CRTh2 rs533116 was associated with allergic asthma in White people (2.67 [1.09-6.55], P < 0.05), and expression of CRTh2 was higher in subjects with allergic airways disease compared to controls (P < 0.05). Among allergic individuals, the AA genotype was significantly associated with more eosinophils and higher expression of CRTh2 by both CD4(+)  T cells and eosinophils (P < 0.05). In vitro, the AA genotype was associated with a higher proportion of CRTh2(+)  cells during Th2 differentiation as well as more IL-4 and IL-13 expression following DK-PGD(2)  stimulation (P < 0.05).
  
  
  CONCLUSIONS
  These findings show an association between CRTh2 rs533116 and allergic asthma and suggest this may be mediated by elevated expression of CRTh2, leading to higher numbers of circulating eosinophils and Th2 cytokine production.
authors.affiliation: Pulmonary Research Group, Division of Pulmonary Medicine, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
authors.forename: E
authors.initials: E
authors.lastname: Campos Alberto
authors.forename: E
authors.initials: E
authors.lastname: Maclean
authors.forename: C
authors.initials: C
authors.lastname: Davidson
authors.forename: N S
authors.initials: NS
authors.lastname: Palikhe
authors.forename: J
authors.initials: J
authors.lastname: Storie
authors.forename: C
authors.initials: C
authors.lastname: Tse
authors.forename: D
authors.initials: D
authors.lastname: Brenner
authors.forename: I
authors.initials: I
authors.lastname: Mayers
authors.forename: H
authors.initials: H
authors.lastname: Vliagoftis
authors.forename: A
authors.initials: A
authors.lastname: El-Sohemy
authors.forename: L
authors.initials: L
authors.lastname: Cameron
mesh_terms: D000328:Adult; D001249:Asthma / Q000235:genetics* / Q000276:immunology; D002454:Cell Differentiation; D016207:Cytokines / Q000096:biosynthesis; D004804:Eosinophils / Q000502:physiology; D005260:Female; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide; D011971:Receptors, Immunologic / Q000235:genetics*; D011982:Receptors, Prostaglandin / Q000235:genetics*; D018418:Th2 Cells / Q000166:cytology
chemical_list: D016207:Cytokines; D011971:Receptors, Immunologic; D011982:Receptors, Prostaglandin; C036293:prostaglandin D2 receptor